Finance

Lists
002821:SHE
Asymchem Laboratories (Tianjin) Co Ltd
CNÂ¥134.61
+0.30%
(+0.40) 1D
Oct 30, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002821...
Open
CNÂ¥132.51
High
CNÂ¥142.00
Low
CNÂ¥127.65
Mkt. cap
47.43B
Avg. vol.
8.49M
Volume
8.86M
Dividend
0.97%
Quarterly dividend
CNÂ¥0.32
Ex-dividend date
Jun 26, 2026
P/E ratio
40.12
52-wk high
CNÂ¥200.00
52-wk low
CNÂ¥88.46
EPS
CNÂ¥3.36
Shares outstanding
334.11M
No. of employees
11K
Open
CNÂ¥132.51
High
CNÂ¥142.00
Low
CNÂ¥127.65
Mkt. cap
47.43B
Avg. vol.
8.49M
Volume
8.86M
Dividend
0.97%
Quarterly dividend
CNÂ¥0.32
Ex-dividend date
Jun 26, 2026
P/E ratio
40.12
52-wk high
CNÂ¥200.00
52-wk low
CNÂ¥88.46
EPS
CNÂ¥3.36
Shares outstanding
334.11M
No. of employees
11K
News stories
From web sources and news partners
About Asymchem Laboratories (Tianjin) Co Ltd
CEOHao Hong
Employees10.6K
FoundedOct 7, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.04B
1.80B
1.80B
1.79B
Cost of goods sold
1.26B
1.03B
1.07B
1.03B
Cost of revenue
1.26B
1.03B
1.07B
1.03B
Research and development expenses
160.19M
126.99M
124.90M
103.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
242.33M
259.12M
255.40M
326.73M
Operating expense
492.26M
373.80M
414.47M
412.60M
Total operating expenses
1.75B
1.40B
1.49B
1.45B
Operating income
285.52M
401.28M
315.69M
341.51M
Other non operating income
49.96M
-115.98M
123.76M
-271.46M
EBT including unusual items
376.44M
333.37M
253.16M
360.99M
EBT excluding unusual items
302.11M
347.91M
273.40M
394.76M
Income tax expense
42.27M
32.21M
40.21M
31.97M
Effective tax rate
11.23%
9.66%
15.88%
8.86%
Other operating expenses
52.60M
-14.90M
30.02M
-23.95M
Net income
332.32M
304.32M
216.14M
331.72M
Net profit margin
16.29%
16.89%
11.97%
18.55%
Earnings per share
-
-
-
-
Interest and investment income
93.79M
65.57M
37.66M
129.06M
Interest expense
-3.36M
-2.97M
-3.24M
-4.81M
Net interest expenses
90.42M
62.60M
34.41M
124.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
407.74M
523.51M
454.57M
473.21M
Gain or loss from assets sale
2.57M
-
4.40M
3.06M
Upcoming events
AI content may include mistakes. Learn more
Google apps